SCHEMBL13313482

SCHEMBL13313482

Cn1cc(O)c2ncccc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.54
SLC6A2 P23975 1/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 5/20 0.47
COMT P21964 2/20 0.46
KDM4E B2RXH2 7/20 0.46
HSP90AA1 P07900 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
IDO1 P14902 2/20 0.46
MAPT P10636 2/20 0.46
FTO Q9C0B1 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
BRD9 Q9H8M2 1/20 0.46
BRD7 Q9NPI1 1/20 0.46
KDM6B O15054 1/20 0.46
KDM6A O15550 1/20 0.46
TET3 O43151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19869862 0.81 BRD4 (0.53) BRD4HTTL3MBTL1KDM4EHSP90AA1
SCHEMBL24556353 0.80 BRD4 (0.51) BRD4L3MBTL1COMTBRD9BRD7
SCHEMBL19869614 0.79 BRD4 (0.50) BRD4L3MBTL1HSP90AA1NPC1BRD9
SCHEMBL24556351 0.79 BRD4 (0.50) BRD4HTTL3MBTL1NPSR1MAPT
SCHEMBL20674196 0.77 HTT (0.46) BRD4SLC6A2HTTL3MBTL1COMT
SCHEMBL11640440 0.76 BRD4 (0.59) BRD4L3MBTL1MAPTBRD9BRD7
SCHEMBL27262498 0.75 BRD4 (0.49) BRD4SLC6A2HTTL3MBTL1KDM4E
SCHEMBL19869860 0.75 BRD4 (0.49) BRD4HTTL3MBTL1KDM4EHSP90AA1
SCHEMBL13439510 0.74 KDM4E (0.44) BRD4SLC6A2HTTL3MBTL1KDM4E
SCHEMBL20674192 0.73 DYRK1A (0.49) BRD4SLC6A2HTTL3MBTL1COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2010-06-24 US disclosed
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2010-06-24 US disclosed
US-7692011-B2 8-hydroxy and 8-mercapto quinazolinones PRANA BIOTECHNOLOGY LIMITED (AU) 2010-04-06 US disclosed
US-7692011-B2 8-hydroxy and 8-mercapto quinazolinones PRANA BIOTECHNOLOGY LIMITED (AU) 2010-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS ACHE, PSEN1, PSEN2 BRD4 1797/4885SLC6A2 404/4885HTT 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.